The candidates vying to be the next London mayor
Enfield Council commits to anti-racism and diversity pledge
President Erdogan promised supporters his party would learn its lessons from the defeat
Mayor of London and London Assembly elections
Off duty Police sergeant Eren Emin catch suspected thief while on stag do
A Century of Urban Transformation, Istanbul’s Evolution
Future Painters Exhibition at Tottenham Hotspur Stadium
Models of Teaching International Journalism for Sustainable Development
English Premier League leaders Arsenal will visit title contenders
Liverpool meet Atalanta and West Ham face Bayer Leverkusen
Arsenal face Bayern Munich and Manchester City play Real Madrid
UK Transfer deadline day, the transfer window closes tonight
Petrol prices on UK forecourts hit 150p a litre
Europe's travel strikes: Flight and train disruption you can expect in April
Enfield Council website achieves digital inclusion recognition
Enfield Council’s Planning Enforcement team goes from strength to strength
People who have received at least two doses of the COVID-19 vaccine are substantially protected against hospitalization if they get infected with the highly contagious omicron variant, according to a research study published on Wednesday.
The London-based Medical Research Council Centre for Global Infectious Disease Analysis carried out a study on omicron patients who tested positive with PCR testing, as well as with those hospitalized for at least one day.
The researchers discovered evidence of a lower risk of hospitalization for omicron infections when compared to the previous delta variant.
“Our estimates suggest that individuals who have received at least two vaccine doses remain substantially protected against hospitalization, even if protection against infection has been largely lost against the omicron variant,” the scientists explained.
A previous infection reduces the risk of any hospitalization by approximately 50%, while also lowering the risk of a hospital stay of more than one day by 61%.
The data showed differences in the effectiveness of vaccines on the omicron variant. “Hazard ratios for hospital attendance with Omicron for Pfizer/Moderna are similar to those seen for Delta in those vaccination categories, while omicron hazard ratios are generally lower than for Delta for the AstraZeneca vaccination categories,” it stated.
